DR. WALTER RALPH WEISS, MD
Osteopathic Medicine at Deepwell Dr, Bethesda, MD

License number

Maryland D0031908

Personal information

See more information about WALTER RALPH WEISS at radaris.com

Name

Address

Phone

Walter Weiss

518 Towson Ave, Luthvle Timon, MD 21093

Walter Weiss, age 81

831 Cedar Grove Rd, Essex, MD 21221

(410) 574-5295

Walter Weiss, age 73

7941 Deepwell Dr, Bethesda, MD 20817

(301) 365-1130

Walter Weiss, age 54

220 E Susquehanna Ave, Towson, MD 21286

(410) 321-6816

Walter Weiss

1604 Gamewell Rd, Silver Spring, MD 20905

(301) 384-0738

Professional information

See more information about WALTER RALPH WEISS at trustoria.com

Dr. Walter R Weiss, Bethesda MD - MD (Doctor of Medicine)

Specialties:

Internal Medicine

Address:

7941 Deepwell Dr, Bethesda 20817
(301) 365-1130 (Phone)
MOBILE MEDICAL CENTER
19735 Germantown Rd, Germantown 20874
(301) 634-9600 (Phone)

Certifications:

Internal Medicine, 1981

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Harvard Medical School
Mt Auburn Hosp
Washington Hospital Center

Malaria Antigen Screening Method

US Patent:

8450055, May 28, 2013

Filed:

Aug 25, 2006

Appl. No.:

11/513439

Inventors:

Joseph T. Bruder - Ijamsville MD, US
Imre Kovesdi - Rockville MD, US
Duncan L. McVey - Derwood MD, US
Douglas E. Brough - Gaithersburg MD, US
C. Richter King - Washington DC, US
Denise Louise Doolan - Camp Hill, AU
Joao Carlos Aguair - Potomac MD, US
Daniel John Carucci - Washington DC, US
Martha Sedegah - Gaithersburg MD, US
Walter R. Weiss - Bethesda MD, US
Keith Limbach - Gaithersburg MD, US

Assignee:

The United States of America as Represented by the Secretary of the Navy - Washington DC

International Classification:

C12Q 1/70, C12N 1/10, A61K 39/00, A61K 39/38, A61K 39/015, C40B 40/02, C40B 50/06

US Classification:

435 5, 4352582, 4241841, 4242681, 4242721, 506 14, 506 26

Abstract:

The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.